Please Upload related files below
Fill in below.
Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery - link your brokerage account with SnapTrade.
On February 27, 2025, Fierce Biotech published an article entitled “Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal.” The article stated that “Teleflex has announced a plan to split its business into two separate independent companies-and it’s setting up one of its future scions with a new portfolio of cardiovascular device assets, set to be acquired from Biotronik.”
Following this news, Teleflex’s stock fell over 21% on the same day.